194 related articles for article (PubMed ID: 32708644)
1. Exploring Drug Treatment Patterns Based on the Action of Drug and Multilayer Network Model.
Yu L; Shi Y; Zou Q; Wang S; Zheng L; Gao L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708644
[TBL] [Abstract][Full Text] [Related]
2. MNBDR: A Module Network Based Method for Drug Repositioning.
Chen HG; Zhou XH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer.
Schnepp PM; Ahmed A; Escara-Wilke J; Dai J; Shelley G; Keller J; Mizokami A; Keller ET
BMC Cancer; 2021 Dec; 21(1):1316. PubMed ID: 34879849
[TBL] [Abstract][Full Text] [Related]
4. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
5. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
6. Endotype-driven Co-module mechanisms of danhong injection in the Co-treatment of cardiovascular and cerebrovascular diseases: A modular-based drug and disease integrated analysis.
Zhang S; Niu Q; Zong W; Song Q; Tian S; Wang J; Liu J; Zhang H; Wang Z; Li B
J Ethnopharmacol; 2024 Sep; 331():118287. PubMed ID: 38705429
[TBL] [Abstract][Full Text] [Related]
7. Network controllability solutions for computational drug repurposing using genetic algorithms.
Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
[TBL] [Abstract][Full Text] [Related]
8. Active Module Identification From Multilayer Weighted Gene Co-Expression Networks: A Continuous Optimization Approach.
Li D; Pan Z; Hu G; Anderson G; He S
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2239-2248. PubMed ID: 32011261
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis of Stromal Molecular Signatures Associated with Breast and Prostate Cancer.
Sun C; Gu Y; Chen G; Du Y
J Comput Biol; 2019 Oct; 26(10):1130-1139. PubMed ID: 31180245
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
[TBL] [Abstract][Full Text] [Related]
11. Integrating systemic module inference with attract method excavates attractor modules for cyclophosphamide contributing to prostate cancer.
Sun G; Zhang W; Wang J
J Cancer Res Ther; 2019 Mar; 15(Supplement):S153-S158. PubMed ID: 30900638
[TBL] [Abstract][Full Text] [Related]
12. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19.
Rivero-García I; Castresana-Aguirre M; Guglielmo L; Guala D; Sonnhammer ELL
Sci Rep; 2021 Oct; 11(1):20687. PubMed ID: 34667255
[TBL] [Abstract][Full Text] [Related]
13. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
[TBL] [Abstract][Full Text] [Related]
14. Exploring disease comorbidity in a module-module interaction network.
Hwang S; Lee T; Yoon Y
J Bioinform Comput Biol; 2020 Apr; 18(2):2050010. PubMed ID: 32404015
[TBL] [Abstract][Full Text] [Related]
15. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide positioning systems network algorithm for in silico drug repurposing.
Cheng F; Lu W; Liu C; Fang J; Hou Y; Handy DE; Wang R; Zhao Y; Yang Y; Huang J; Hill DE; Vidal M; Eng C; Loscalzo J
Nat Commun; 2019 Aug; 10(1):3476. PubMed ID: 31375661
[TBL] [Abstract][Full Text] [Related]
17. Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers.
Goody D; Gupta SK; Engelmann D; Spitschak A; Marquardt S; Mikkat S; Meier C; Hauser C; Gundlach JP; Egberts JH; Martin H; Schumacher T; Trauzold A; Wolkenhauer O; Logotheti S; Pützer BM
Theranostics; 2019; 9(5):1490-1509. PubMed ID: 30867845
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
19. Weighted gene co-expression network analysis of the salt-responsive transcriptomes reveals novel hub genes in green halophytic microalgae Dunaliella salina.
Panahi B; Hejazi MA
Sci Rep; 2021 Jan; 11(1):1607. PubMed ID: 33452393
[TBL] [Abstract][Full Text] [Related]
20. Integrating genomics and proteomics data to predict drug effects using binary linear programming.
Ji Z; Su J; Liu C; Wang H; Huang D; Zhou X
PLoS One; 2014; 9(7):e102798. PubMed ID: 25036040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
